2017 Update for Type 2 Diabetes Comprehensive Management Algorithm Published By American Association of Clinical Endocrinologists, American College of Endocrinology

Tuesday, January 10, 2017 5:28 pm EST

Dateline:

JACKSONVILLE, Fla.
"Both the guidelines and algorithm, while detailed, are constructed to address specific problems in diabetes care in a concise, practical and actionable manner that will assist clinical caregivers with developing patient care plans"

JACKSONVILLE, Fla.--(BUSINESS WIRE)--The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) today announced the publication of an update to its Comprehensive Type 2 Diabetes Management Algorithm.

Designed to serve as a practical and easy-to-use decision-making tool for patients’ medical management, the 2017 algorithm emphasizes obesity as one of the underlying risk factors for type 2 diabetes (T2D) and its microvascular complications, reiterating the organizations’ recently published position that obesity is fundamentally a chronic, complications-centric, progressive disease requiring long-term commitment to weight loss and maintenance lifestyle therapies.

Specifically, it states that weight loss therapy consisting of a lifestyle prescription that incorporates a reduced-calorie healthy meal plan, prescribed physical activity and behavioral intervention should be considered in all patients with prediabetes and T2D who also are diagnosed as overweight or obese. Further, it recommends consideration of weight loss medications approved for the chronic management of obesity if necessary to achieve the degree of weight loss required to reach prediabetes or T2D therapeutic goals.

The algorithm also focuses on stratified cardiovascular risk factors and treatment recommendations based on a patient’s risk profile, as well as detailed assessment of all FDA-approved antidiabetic medications and their impact on congestive heart failure and atherosclerotic cardiovascular disease.

“Incorporating an emphasis on obesity and the role it plays in the development and management of type 2 diabetes, and necessary weight loss therapies into our algorithm update, as well as details regarding the evaluation and treatment of cardiovascular risks, should provide helpful guidance to physicians in providing optimal care to their patients,” said Algorithm Task Force Chair Alan J. Garber, MD, PhD, FACE.

“Both the guidelines and algorithm, while detailed, are constructed to address specific problems in diabetes care in a concise, practical and actionable manner that will assist clinical caregivers with developing patient care plans,” he added.

The Comprehensive Diabetes Management Algorithm 2017 Update is published online at https://www.aace.com/publications/algorithm and is scheduled for publication in the February 2017 issue (Volume 23, Issue 2) of the association’s monthly peer-reviewed scientific journal Endocrine Practice.

About the American Association of Clinical Endocrinologists (AACE)

The American Association of Clinical Endocrinologists (AACE) represents more than 7,000 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in endocrinology, diabetes and metabolism and concentrate on the treatment of patients with endocrine and metabolic disorders including diabetes, thyroid disorders, osteoporosis, growth hormone deficiency, cholesterol disorders, hypertension and obesity. Visit our site at http://www.aace.com.

About the American College of Endocrinology (ACE)

The American College of Endocrinology (ACE) is the charitable, educational and scientific arm of the American Association of Clinical Endocrinologists (AACE). ACE is the leader in advancing the care and prevention of endocrine and metabolic disorders by: providing professional education and reliable public health information; recognizing excellence in education, research and service; promoting clinical research and defining the future of Clinical Endocrinology. For more information, please visit http://www.aace.com/college/.

About the Journal

Endocrine Practice , the official journal of the American College of Endocrinology (ACE) and the American Association of Clinical Endocrinologists (AACE), is a peer-reviewed journal published twelve times a year. The Journal publishes the latest information in the treatment of diabetes, thyroid disease, obesity, growth hormone deficiency, sexual dysfunction and osteoporosis, and contains original articles, case reports, review articles, commentaries, editorials, visual vignettes, as well as classified and display advertising. Special issues of Endocrine Practice also include AACE clinical practice guidelines and other AACE/ACE white papers. Complete content is available on the Endocrine Practice website at http:journals.aace.com.

Contact:

American Association of Clinical Endocrinologists
Glenn Sebold, 904-353-7878 Ext. 122
gsebold@aace.com